Norvasc and Hypocoagulable state - a phase IV clinical study of FDA data

Summary:

Hypocoagulable state is reported as a side effect among people who take Norvasc (amlodipine besylate), especially for people who are male, 60+ old, also take Ketek, and have Diabetes.

The phase IV clinical study analyzes which people have Hypocoagulable state when taking Norvasc. It is created by eHealthMe based on reports of 133,505 people who have side effects when taking Norvasc from the FDA, and is updated regularly.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.

What is Hypocoagulable state?

Hypocoagulable state (abnormality of blood coagulation that increases the risk of thrombosis) is found to be associated with 135 drugs and 289 conditions by eHealthMe. Check the latest studies of Hypocoagulable state.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

133,505 people reported to have side effects when taking Norvasc.
Among them, 11 people (0.01%) have Hypocoagulable state.

Could Norvasc cause Hypocoagulable state?

Among these 11 people:

What is the gender of people who have Hypocoagulable state when taking Norvasc? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Hypocoagulable state when taking Norvasc? *

What are other drugs people take besides Norvasc? *

What are other side effects people have besides Hypocoagulable state? *

Liver Disorder (liver diseases): 4 people, 36.36%
Interstitial Lung Disease: 4 people, 36.36%
Alanine Aminotransferase Increased: 3 people, 27.27%
Aspartate Aminotransferase Increased: 3 people, 27.27%
Blood Lactate Dehydrogenase Increased: 3 people, 27.27%
Gamma-Glutamyltransferase Increased: 3 people, 27.27%
Blood Sodium Decreased: 2 people, 18.18%
Red Blood Cell Count Decreased: 2 people, 18.18%
International Normalised Ratio Increased: 2 people, 18.18%
Blood Alkaline Phosphatase Increased: 2 people, 18.18%

What are the existing conditions these people have? *

Diabetes: 5 people, 45.45%
Pneumonia: 4 people, 36.36%
Heart Attack: 4 people, 36.36%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 27.27%
Gastritis (inflammation of stomach): 2 people, 18.18%
Essential Hypertension (primary hypertension): 1 person, 9.09%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Hypocoagulable state?

- Check whether Hypocoagulable state is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norvasc:

Norvasc (136,738 reports)

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypocoagulable state:

Hypocoagulable state (135 drugs)

Browse all the conditions that are associated with Hypocoagulable state:

Hypocoagulable state (289 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.